The Place and Prognostic Value of TERT Promoter Mutation in Molecular Classification in Grade II-III Glial Tumors and Primary Glioblastomas
Objective: Diffuse gliomas, the most common primary malignant brain tumors, have been classified by the World Health Organization as class II-IV gliomas. After 2016, two mutations in the promoter region of the telomerase reverse transcriptase (TERT) gene were identified in addition to the IDH, 1p /...
Main Authors: | Neslihan Kaya TERZI, Ismail YILMAZ, Aysim Buge OZ |
---|---|
Format: | Article |
Language: | English |
Published: |
Federation of Turkish Pathology Societies
2022-05-01
|
Series: | Türk Patoloji Dergisi |
Subjects: | |
Online Access: |
http://www.turkjpath.org/pdf.php3?id=1991
|
Similar Items
-
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target?
by: Vincenzo Di Nunno, et al.
Published: (2023-12-01) -
Detection of <i>TERT</i> Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances
by: Tsimur Hasanau, et al.
Published: (2022-03-01) -
pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma
by: Leyla Blanco-García, et al.
Published: (2023-08-01) -
TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas
by: Feng Tang, et al.
Published: (2023-08-01) -
<i>TERT</i> Promoter Mutations Increase Sense and Antisense Transcription from the <i>TERT</i> Promoter
by: François Hafezi, et al.
Published: (2021-11-01)